News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

35,144 signal articles · 107 in last 24h · 178,660 total before filter · latest 1h ago

107last 24h

3126last 7d

511● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1820 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: EDSAsentiment: neutralSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

GlobeNewswire4d agoneutral

Edesa Biotech to Present at Guggenheim Healthcare Innovation Conference

EDSA

GlobeNewswire24d agoneutral

Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study

EDSA

Simply Wall St.72d agoneutral

3 Small Cap Biotech Stocks Trading At A Discount With Late Stage Clinical Catalysts

EDSA

Zacks Small Cap Research76d agoneutral

EDSA: Recruitment in Phase 2 Vitiligo Study Set to Get Underway

EDSA

Benzinga80d agoneutral

Edesa Biotech Stock Sinks After Fresh Capital Raise

EDSA

GlobeNewswire81d agoneutral

Edesa Biotech Announces Pricing of $25.0 Million Public Offering

EDSA

MT Newswires81d agoneutral

Edesa Biotech Launches Public Offering of Common Shares, Warrants

EDSA

GlobeNewswire81d agoneutral

Edesa Biotech Announces Proposed Public Offering

EDSA

GlobeNewswire87d agoneutral

Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results

EDSA

MT Newswires156d agoneutral

Sector Update: Healthcare Stocks Gain Friday Afternoon

EDSA

MT Newswires156d agoneutral

Top Midday Stories: Lululemon Down After Fiscal Q1 Results; Amazon Engineers Criticize AI Spending; Hoffman to Exit Microsoft Board

AMZN EDSA LULU META MSFT NVDA

Insider Monkey202d agoneutral

Edesa Biotech (EDSA) Reaffirms 2026 Clinical Study Timeline for Vitiligo Treatment

EDSA

Associated Press Finance257d agoneutral

BC-Most Active Stocks

EDSA

Simply Wall St.376d agoneutral

Favourable Signals For Edesa Biotech: Numerous Insiders Acquired Stock

EDSA